ARCHIVES

Private Sector Still Valuable To National Cancer Program, ACS Research Chief Says

This article is from The Cancer Letter archive.

Vol. 01 No. 12 | April 26, 1974

Download PDF Visit The Full Archive

Related Articles

Bush To Propose Increase for Cancer Screening, FDA Generics Reviews

January 31, 2003

Industry Groups Lobby for Lower Standards for FDA Approval

November 18, 2011

Impact Of DRGs On Clinical Research Less Than First Feared, Speakers Tell NIH Directors Meeting

June 20, 1986

Cetuximab Plus Chemoradiation Boosts Survival in Phase II Study

June 24, 2011

“Landmark” Fundings Reported n Interferon Genes, Ovarian And Pancreas Markers

April 17, 1981

In Brief: NIH Budget Cut Being Considered, Threatening NCI’s Plan For Reaching Year 2000 Goals

December 13, 1984